申请人:Universite de Nantes
公开号:EP3650447A1
公开(公告)日:2020-05-13
The present invention relates to a compound having the following formula (I):
wherein:
- A is a (hetero)aryl radical comprising from 5 to 10 carbon atoms, possibly substituted by at least one substituent chosen from the group consisting of: halogen atoms, amino, azido, cyano, nitro, hydroxyl, formyl, carboxyl, amido, (C1-C6)alkyl groups, halo(C1-C6)alkyl groups, (C1-C6)alkoxy groups, alkenyl groups, cycloalkenyl groups, and alkynyl groups, and
- R is H, CN or CF3,
or their pharmaceutically acceptable salts, racemates, diastereomers or enantiomers.
本发明涉及一种具有下式 (I) 的化合物:
其中
- A 是由 5 至 10 个碳原子组成的(杂)芳基,可能被至少一个取代基取代,该取代基选 自以下组成的组:卤素原子、氨基、叠氮基、氰基、硝基、羟基、甲酰基、羧基、 氨基、(C1-C6)烷基、卤代(C1-C6)烷基、(C1-C6)烷氧基、烯基、环烯基和炔基,以及
- R 是 H、CN 或 CF3、
或它们的药学上可接受的盐、外消旋体、非对映异构体或对映体。